← RESMED INC RMD
Market Price
$224.35
Market Cap
$32.89B
P/E Ratio
23.59
Revenue (FY 2025)
↑9.8% YoY
$5.15B
3-Yr CAGR: 12.9%
Net Income
↑37.2% YoY
$1.40B
Net Margin: 27.2%
Free Cash Flow
↑27.6% YoY
$1.66B
FCF Yield: 5.05%
EPS (Diluted)
↑37.4% YoY
$9.51
Basic: $9.55
Return on Equity
Efficiency
23.5%
ROA: 326.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (RMD)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,838.7M | — | $1,066.5M | $352.4M | — | $2.49 | — | $547.9M | $489.4M | — |
| FY 2017 | $2,066.7M | +12.4% | $1,201.7M | $342.3M | -2.9% | $2.40 | -3.6% | $414.1M | $351.8M | -28.1% |
| FY 2018 | $2,340.2M | +13.2% | $1,362.2M | $315.6M | -7.8% | $2.19 | -8.8% | $505.0M | $442.4M | +25.8% |
| FY 2019 | $2,606.6M | +11.4% | $1,536.6M | $404.6M | +28.2% | $2.80 | +27.9% | $459.1M | $390.3M | -11.8% |
| FY 2020 | $2,957.0M | +13.4% | $1,717.8M | $621.7M | +53.7% | $4.27 | +52.5% | $802.3M | $706.9M | +81.1% |
| FY 2021 | $3,196.8M | +8.1% | $1,839.1M | $474.5M | -23.7% | $3.24 | -24.1% | $736.7M | $634.0M | -10.3% |
| FY 2022 | $3,578.1M | +11.9% | $2,024.3M | $779.4M | +64.3% | $5.30 | +63.6% | $351.1M | $216.3M | -65.9% |
| FY 2023 | $4,223.0M | +18.0% | $2,355.7M | $897.6M | +15.2% | $6.09 | +14.9% | $693.3M | $573.6M | +165.2% |
| FY 2024 | $4,685.3M | +10.9% | $2,655.3M | $1,021.0M | +13.7% | $6.92 | +13.6% | $1,401.3M | $1,301.8M | +126.9% |
| FY 2025 | $5,146.3M | +9.8% | $3,055.0M | $1,400.7M | +37.2% | $9.51 | +37.4% | $1,751.6M | $1,661.7M | +27.6% |
Valuation
Market Price
$224.35
Market Cap
$32.89B
Enterprise Value
N/A
P/E Ratio
23.59
P/B Ratio
5.45
FCF Yield
5.05%
Dividend Yield
0.94%
Shares Outstanding
Profitability & Margins
Gross Margin
59.36%
Operating Margin
32.75%
Net Margin
27.22%
Return on Equity (ROE)
23.47%
Return on Assets (ROA)
326.55%
Asset Turnover
12.00x
Revenue 3-Yr CAGR
12.88%
Financial Health & Liquidity
Current Ratio
1.07
Cash Ratio
3.01
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$1.21B
Total Debt
N/A
Book Value / Share
$41.14
Cash Flow Efficiency
Operating Cash Flow
$1.75B
Capital Expenditures (CapEx)
$89.86M
Free Cash Flow
$1.66B
OCF / Revenue
34.04%
FCF / Revenue
32.29%
FCF 3-Yr CAGR
97.31%
Per Share Metrics
EPS (Diluted)
$9.51
EPS (Basic)
$9.55
Dividends / Share
$2.12
Book Value / Share
$41.14
EPS YoY Growth
37.43%
Balance Sheet (FY 2025)
Total Assets
$428.95M
Total Liabilities
$402.25M
Stockholders' Equity
$5.97B
Current Assets
$428.95M
Current Liabilities
$402.25M